Sort
48,018 grants matching “immunotherapy”
CD19 Directed CAR Therapy
$504,482Carl H. June · University Of Pennsylvania · R01 · FY2015 · CA
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
$504,471Gary Kohanbash · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Multi-color laser particles for high-throughput pooled analysis
$504,400Seok H Yun · Massachusetts General Hospital · R01 · FY2024 · EB
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
$504,389Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Nanoscale Metal-Organic Frameworks Enable Radiotherapy-Radiodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Generate Tumor Vaccines and Potentiate Immunotherapy of Head and Neck Cancers
$504,359Wenbin Lin · University Of Chicago · R01 · FY2021 · CA
Resource for Nonhuman Primate Immune Reagents
$504,257Francois J Villinger · Emory University · R24 · FY2015 · OD
Cytokines in AIDS and Cancer
$504,219George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
$504,213Arvin Dar · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Training Program in Immunology
$504,144Gwendalyn J Randolph · Washington University · T32 · FY2019 · AI
Christiana Care CCOP
$504,125Christiana Care Health Services, Inc. · U10 · FY2002 · CA
Role of histotripsy synergized CD40 signaling in the re-engineering of cold tumors
$504,109Ashish Ranjan · Ut Southwestern Medical Center · R01 · FY2025 · CA
Amyloid-Lowering Small Molecule AB-Binding Agents in AD
$504,093William E Klunk · University Of Pittsburgh At Pittsburgh · U01 · FY2010 · AG
Gasdermin E and pyroptosis in cancer
$504,066Judy Lieberman · Boston Children'S Hospital · R01 · FY2020 · CA
Gasdermin E and pyroptosis in cancer
$504,066Judy Lieberman · Boston Children'S Hospital · R01 · FY2021 · CA
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine
$503,987William E Gillanders · Washington University · P50 · FY2018 · CA
LUNG SQUAMOUS CELL CARCINOMA STEM CELLS AS IMMUNOTHERAPY TARGETS
$503,978Children'S Hospital Corporation, The · · FY2016 · Department of the Army
Functional Immunomics Core
$503,887Bing Li · University Of Louisville · P20 · FY2021 · GM
Training In Cell and Gene Therapy
$503,875Helen E Heslop · Baylor College Of Medicine · T32 · FY2024 · HL
Development of novel AAV vaccine strategy in a pre-clinical model of oral melanoma.
$503,863George V Aslanidi · University Of Minnesota · R01 · FY2024 · CA
Listeria Immunotherapy for Pancreatic and Ovarian Cancer
$503,783Cerus Corporation · R44 · FY2005 · CA
Inhibitory Pathways Underlying Viral Persistence In Vivo
$503,775Elina I Zuniga · University Of California, San Diego · R01 · FY2023 · AI
Inhibitory Pathways Underlying Viral Persistence In Vivo
$503,775Elina I Zuniga · University Of California, San Diego · R01 · FY2024 · AI
Inhibitory Pathways Underlying Viral Persistence In Vivo
$503,775Elina I Zuniga · University Of California, San Diego · R01 · FY2025 · AI
AHR-mediated immunosuppression in glioblastoma
$503,741Francisco J. Quintana · Brigham And Women'S Hospital · R01 · FY2019 · ES
Targeting the cancer glycocalyx
$503,708Carolyn R Bertozzi · Stanford University · R01 · FY2024 · CA